Tandem Diabetes Care, Inc. (TNDM)

NASDAQ: TNDM · Real-Time Price · USD

19.50

+0.49 (2.58%)

At close: Jul 31, 2026, 4:00 PM EDT

19.44

-0.06 (-0.29%)

After-hours: Jul 31, 2026, 7:49 PM EDT

Tandem Diabetes Care Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	179.33	90.63	69.23	58.87	172.52	71.18
Short-Term Investments	390.93	202.03	369.1	409.04	444.38	552.63
Cash & Short-Term Investments	570.26	292.67	438.33	467.91	616.9	623.81
Cash Growth	54.70%	-33.23%	-6.32%	-24.15%	-1.11%	28.64%
Accounts Receivable	140.67	165.49	114.59	105.56	114.72	110.73
Inventory	126.4	128.77	149.61	157.94	111.12	68.55
Other Current Assets	49.77	31.22	21.97	16.59	7.24	8.43
Total Current Assets	887.1	618.14	724.49	747.99	849.98	811.52
Net Property, Plant & Equipment	178.99	179.75	163.46	164.33	179.18	77.89
Long-Term Investments	56.49	60.35	74.55	40.34	-	-
Other Long-Term Assets	30.82	22.87	5.17	-	23.63	15.73
Total Assets	1,153	881.11	967.66	952.66	1,053	905.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	59.86	47.07	44.73	49.59	55.73	28.03
Accrued Expenses	74.93	91.42	82.3	56.16	48.28	60.98
Current Portion of Long-Term Debt	-	-	40.67	-	-	-
Current Portion of Leases	20.11	19.47	18.21	17.06	13.12	9.28
Unearned Revenue	8.95	9.53	11.83	43.99	18.84	10.18
Other Current Liabilities	84.1	75.24	49.31	28.46	29.33	23.39
Total Current Liabilities	247.96	242.72	247.05	195.26	165.29	131.86
Long-Term Debt	601.77	310.04	308.27	285.04	283.23	281.47
Long-Term Leases	112.86	114.97	106.42	113.57	123.52	23.92
Other Long-Term Liabilities	58.41	58.22	42.82	45.16	40.79	34.78
Total Long-Term Liabilities	773.03	483.22	457.51	443.77	447.55	340.17
Total Liabilities	1,021	725.94	704.56	639.03	612.84	472.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.07	0.07	0.07	0.07	0.07	0
Additional Paid-in Capital	1,400	1,402	1,313	1,264	1,171	1,068
Accumulated Other Comprehensive Income	5.04	5.59	-1.95	1.37	-1.82	-0.62
Retained Earnings	-1,273	-1,253	-1,048	-951.8	-729.19	-634.6
Shareholders' Equity	132.4	155.17	263.1	313.63	439.95	433.11
Total Liabilities & Equity	1,153	881.11	967.66	952.66	1,053	905.14

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	734.74	444.48	473.57	415.67	419.88	314.67
Net Cash (Debt)	-164.48	-151.81	-35.24	52.25	197.02	309.14
Net Cash Growth	-	-	-	-73.48%	-36.27%	20.47%
Net Cash Per Share	-2.43	-2.26	-0.54	0.80	3.07	4.80
Book Value	132.4	155.17	263.1	313.63	439.95	433.11
Book Value Per Share	1.95	2.31	4.02	4.83	6.86	6.73
Tangible Book Value	132.4	155.17	263.1	313.63	439.95	433.11
Tangible Book Value Per Share	1.95	2.31	4.02	4.83	6.86	6.73

SEC Filings: 10-K · 10-Q